DAR Q3 Earnings Surpass Estimates on Solid Feed Performance

Darling Ingredients reported Q3 2026 EPS of $1.67 versus $0.12 a year earlier and $1.64 consensus; sales rose 14.5% to $1.791 billion, narrowly beating estimates. Combined adjusted EBITDA climbed 110% to $514.3 million, while the company reaffirmed fiscal 2026 guidance of $2.2-$2.3 billion and expects year-end net debt at or below $3.0 billion. Net debt fell $420.3 million in the quarter, and Darling repurchased $75.9 million of stock.

Analysis

DAR’s earnings quality is better than the headline EPS suggests, but less uniformly strong than the adjusted-EBITDA jump: the $63.5 million business-sale gain is nonrecurring, while DGD’s swing and segment results remain exposed to renewable-fuel economics. The key read-through is operating leverage across both sides of the model: stronger product pricing lifted Feed Ingredients, while DGD improved sharply. That creates upside when renewable-fuel margins and fats pricing cooperate, but also makes earnings vulnerable if biofuel downtime or weaker demand pushes down fat values. Integration can cushion sourcing risk, not eliminate commodity exposure.

The market may be pricing a durable recovery after DAR’s substantial year-long appreciation. Reaffirmed guidance is supportive, yet it is not an upgrade; Q4 expectations also depend partly on management’s predicted reversal of timing and operational disruptions. Treat that as a verification item, not booked recovery. Deleveraging is constructive, but higher capex and repurchases compete with balance-sheet repair if cash generation softens.

Over the next 1–3 months, test the thesis against Q4 DGD margins per gallon, Feed Ingredients margins, and net debt progress—not headline EPS. Over 6–18 months, renewable-fuel policy and the regulatory outcome for the Tessenderlo joint venture could alter economics and portfolio focus. A deterioration in fats pricing, weaker DGD unit economics, or failure to approach the net-debt target would challenge the bull case.

Key Decisions for Investors

• Avoid chasing the post-run strength; keep DAR neutral near term. Consider a staged long only on a material pullback if guidance holds and DGD unit economics remain sound. No defensible price target is available from the supplied data.
• For the next earnings update, verify whether Q4 DGD profitability actually recovers: monitor EBITDA per gallon, production versus shipments, and the contribution from timing reversals. Failure to improve would falsify the near-term recovery thesis.
• Track Feed Ingredients gross margin and global fat prices as an early warning for a reversal in pricing-led gains; weaker margins alongside slowing volumes would argue to reduce exposure.
• Monitor net debt versus management’s year-end target, capex, and Tessenderlo JV regulatory progress over the next 1–3 months. If deleveraging stalls or the JV is delayed, reassess the valuation support from portfolio simplification and capital returns.